Tag: NRx Pharmaceuticals

Articles and events tagged with this topic across BioBuzz’s regional hubs.

Articles

Career & Professional Development 225 Events 86 Funding 206 Industry Trends 1291 Manufacturing 151 People 694 Policy 82 Real Estate 201 Research 325 Workforce 147

5 Questions With 223 Ambassadors of Buzz 16 Annual Awards 10 Career Tips 12 Chronicles in Leadership 1 Editorial 320 Featured Employer 12 In Conversation 120 People on the Move 35 Press Release 965 Quick Hits 158 Sponsored Content 129 Talent Lab 36 The XYZ 1

From To

0 filters

Showing 0 of 0 results

BioHealth Capital Region Industry Trends Press Release

NRx Pharmaceuticals Announces Data Safety Monitoring Board (DSMB) Update on U.S. National Institutes of Health (NIH) Study of ZYESAMI® (aviptadil) in Critical COVID-19

December 2, 2024

BioHealth Capital Region

Research Triangle Park Industry Trends Press Release

FDA Declines Emergency Use Authorization for ZYESAMI® (aviptadil) for subgroup of Patients with Critical COVID-19 at immediate risk of death from respiratory failure despite treatment with approved therapy, including remdesivir

December 2, 2024

Research Triangle Park

Events

No upcoming events tagged “NRx Pharmaceuticals”.

Explore

News
Events
Resources & Tools

Company

About Us
Team
History
Contact

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.